Intravitreal functional plasminogen is elevated in central retinal vein occlusion.
OBJECTIVE
To detect intravitreal functional plasminogen in vitreous samples of patients with recent onset of central retinal vein occlusion (CRVO) and to demonstrate significantly higher intravitreal plasminogen in CRVO patients in comparison to controls.


METHODS
Prospective clinical case series of 13 consecutive patients with recent onset of CRVO scheduled for core pars plana vitrectomy and 10 consecutive patients undergoing standard pars plana vitrectomy for routine macular surgery or vitreal floater removal. In all 23 cases, vitreous taps were extracted from the central vitreous body, and plasminogen was functionally determined in a new ultrasensitive p-nitroanilide reaction after activation with streptokinase (100% of normal, %N = functional plasminogen in pooled normal citrated plasma).


RESULTS
Plasminogen was detected in all analyzed samples (n = 23), and mean plasminogen was revealed to be 1.33 ± 1.73% (mean ± SD), with a range of 0.03-7.8%N. Patients with recent onset of CRVO exhibited significantly higher intravitreal plasminogen (2.19 ± 1.89%N) in comparison to controls (0.20 ± 0.21%N; p < 0.001, Mann-Whitney U test).


CONCLUSIONS
Due to significantly increased intravitreal plasminogen in patients with recent onset of CRVO, intravitreally administered tissue plasminogen activator might be an option to induce posterior vitreous detachment (enzymatic vitreolysis) in CRVO patients.
Department of Ophthalmology, Philipps University, Marburg, Germany.
Thomas
T
Bertelmann
Stefan
S
Mennel
Walter
W
Sekundo
Stefan
S
Strodthoff
Michael C P
MC
Witteborn
Thomas
T
Stief
Nauke
N
Nguyen
Michael J
MJ
Koss
D000368:Aged; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010958:Plasminogen / Q000378:metabolism*; D011446:Prospective Studies; D012170:Retinal Vein Occlusion / Q000378:metabolism*; D014822:Vitreous Body / Q000378:metabolism*
D010958:Plasminogen